Status: current, Defined. Date: 30-Sep 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4741881000168117 | Oxonal 5/2.5 (naloxone hydrochloride 2.5 mg + oxycodone hydrochloride 5 mg) modified release tablet, 28 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4741891000168119 | Oxonal 5/2.5 modified release tablet, 28, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Oxonal 5/2.5 modified release tablet, 28, blister pack | Is a | Oxonal 5/2.5 modified release tablet, 28 | true | Inferred relationship | Some | ||
| Oxonal 5/2.5 modified release tablet, 28, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Oxonal 5/2.5 modified release tablet, 28, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Oxonal 5/2.5 modified release tablet, 28, blister pack | has TP | Oxonal 5/2.5 | true | Inferred relationship | Some | ||
| Oxonal 5/2.5 modified release tablet, 28, blister pack | has TPUU | Oxonal 5/2.5 modified release tablet | true | Inferred relationship | Some | 431993928 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Schedule 8 medications reference set
Containered trade product pack reference set
FHIR